Key Highlights
•
A new gene therapy using a virus to deliver small RNA molecules successfully silenced a harmful virus-like protein in mice, slowing the progression of ALS-like symptoms and protecting motor neurons. This provides compelling evidence for a novel treatment strategy targeting a specific genetic culprit in some forms of ALS.
Source →
•
Genetic analysis has pinpointed specific gene variants in TMEM106B, ACE, and ERC2 that are shared between Alzheimer’s disease and major psychiatric disorders like depression and anxiety. This discovery reveals the biological links behind common neuropsychiatric symptoms in Alzheimer’s and could lead to better, targeted treatments.
Source →
•
A pilot study found that people with facioscapulohumeral muscular dystrophy (FSHD) appear to develop the autoimmune condition myasthenia gravis more frequently than expected, suggesting a novel disease association. This is important because myasthenia gravis is treatable, so recognizing this link could lead to timely diagnosis and life-saving intervention for FSHD patients.
Source →
•
Researchers have developed a new blood test that detects antibodies to a specific protein motif linked to Epstein-Barr virus, which could help predict the risk of developing multiple sclerosis. This tool represents a significant step towards early identification and intervention for MS, a disease strongly associated with this common virus.
Source →
•
EEG brainwave analysis reveals a measurable imbalance in brain dynamics in people with obesity, providing objective evidence that weight affects brain function. This finding opens new avenues for understanding the neurological components of obesity and could inform future therapeutic approaches.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
